Cargando...
Precision medicine in lupus nephritis: can biomarkers get us there?
Patients with systemic lupus erythematosus (SLE) frequently develop lupus nephritis (LN), a condition that can lead to end stage kidney disease (ESKD). Multiple serum and urine biomarkers for LN have been proposed in recent years, yet none have become incorporated into clinical use. The majority of...
Gardado en:
| Publicado en: | Transl Res |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2018
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6415919/ https://ncbi.nlm.nih.gov/pubmed/30179587 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.trsl.2018.08.002 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|